ACCESSION: MSBNK-SMB_Measured-HSA032P0246004
RECORD_TITLE: Characterized; Asparaginyl-Isoleucine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'RA1-pos_1727': {'bp': 9063.0, 'sum': 49453.0}, 'HC12-pos_1609': {'bp': 3818.0, 'sum': 32678.0}, 'RA2-pos_1654': {'bp': 2933.0, 'sum': 25875.0}, 'RA10-pos_1544': {'bp': 2721.0, 'sum': 20919.0}, 'RA20-pos_1606': {'bp': 2456.0, 'sum': 21900.0}, 'HC5-pos_1636': {'bp': 1813.0, 'sum': 13440.0}, 'RA17-pos_1512': {'bp': 1789.0, 'sum': 15726.0}, 'HC1-pos_1564': {'bp': 1743.0, 'sum': 17457.0}, 'RA5-pos_1679': {'bp': 1673.0, 'sum': 14897.0}, 'RA23-pos_1470': {'bp': 1666.0, 'sum': 12570.0}, 'HC4-pos_1553': {'bp': 1356.0, 'sum': 13378.0}, 'HC21-pos_1443': {'bp': 1199.0, 'sum': 10657.0}, 'RA24-pos_1358': {'bp': 978.0, 'sum': 7380.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 246.143889
COMMENT: PRECURSOR_M/Z_STDEV 0.000838
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 13.556; C9H20N5OP; [M+H]+; delta(ppm) -13.555673
COMMENT: PROPOSED_MF SevenGoldenRules 8.102; C8H24NO5P; [M+H]+; delta(ppm) -8.101585
COMMENT: PROPOSED_MF SevenGoldenRules 1.363; C10H19N3O4; [M+H]+; delta(ppm) -1.362502
COMMENT: PROPOSED_MF MS-FINDER 3.977; C10H19N3O4; [M+H]+; delta(ppm) -1.359152
COMMENT: PROPOSED_MF MS-FINDER 2.870; C6H15N9O2; [M+H]+; delta(ppm) 9.550494
COMMENT: PROPOSED_MF MS-FINDER 2.496; C11H15N7; [M+H]+; delta(ppm) -6.792558
COMMENT: PROPOSED_MF MS-FINDER 2.483; C6H23N5OS2; [M+H]+; delta(ppm) 11.453466
COMMENT: PROPOSED_MF SIRIUS5_Sirius 59.729; C10H19N3O4; [M+H]+; delta(ppm) -1.359152
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.497; C13H18F3N; [M+H]+; delta(ppm) -7.767790
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H19N3O4; [M+H]+; delta(ppm) -1.359152
COMMENT: PROPOSED_MF SIRIUS6_Sirius 100.079; C10H19N3O4; [M+H]+; delta(ppm) -1.359152
COMMENT: PROPOSED_MF SIRIUS6_Sirius 84.924; C8H17N6O3; [M+H]+; delta(ppm) 4.095641
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.965; C8H18F3N3O2; [M+H]+; delta(ppm) 8.575230
COMMENT: PROPOSED_MF SIRIUS6_Sirius 55.573; C9H23N3OSi2; [M+H]+; delta(ppm) -206214.374080
COMMENT: PROPOSED_MF SIRIUS6_Sirius 54.581; C6H15N9O2; [M+H]+; delta(ppm) 9.550494
COMMENT: PROPOSED_MF SIRIUS6_Sirius 54.469; C11H15N7; [M+H]+; delta(ppm) -6.792558
COMMENT: PROPOSED_MF SIRIUS6_Sirius 51.227; C10H20FN3OSi; [M+H]+; delta(ppm) -206209.254081
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.299; C7H18N8P; [M+H]+; delta(ppm) -8.048319
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.154; C10H23N3SSi; [M+H]+; delta(ppm) -206214.958695
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.004; C11H20FN3S; [M+H]+; delta(ppm) 4.163864
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H19N3O4; [M+H]+; delta(ppm) -1.359152
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.782; HXWUJJADFMXNKA-UHFFFAOYNA-N; [M+H]+; CC(C)CC(NC(=O)C(N)CC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.629; MLTRLIITQPXHBJ-UHFFFAOYNA-N; [M+H]+; CC(C)CC(N)C(=O)NC(CC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.613; VWHGTYCRDRBSFI-ZETCQYMHSA-N; [M+H]+; CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.612; MQLZLIYPFDIDMZ-UHFFFAOYNA-N; [M+H]+; CCC(C)C(NC(=O)C(N)CC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.526; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; CC[C@H](C)[C@H](NC(=O)CNC(=O)CN)C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.865; MQLZLIYPFDIDMZ-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Isoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.856; HXWUJJADFMXNKA-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Leucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.762; MLTRLIITQPXHBJ-UHFFFAOYNA-N; [M+H]+; Leucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.746; HZYHBDVRCBDJJV-UHFFFAOYNA-N; [M+H]+; Isoleucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.602; XPJBQTCXPJNIFE-SSDOTTSWSA-N; [M+H]+; Gly-Gly-D-Leu
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.551; XXDVDTMEVBYRPK-UHFFFAOYNA-N; [M+H]+; Valyl-Glutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.543; QNBHZXFGRLNYRY-UHFFFAOYSA-N; [M+H]+; [4-[(2-amino-2-methylpropanoyl)amino]cyclohexyl] nitrate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.530; MRVYVEQPNDSWLH-BTBXXMRTNA-N; [M+H]+; Glutaminylvaline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.489; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; Gly-Gly-Ile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.442; VWHGTYCRDRBSFI-ZETCQYMHSA-N; [M+H]+; Leu-Gly-Gly
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.437; CGADBKNPQUQOIP-UHFFFAOYSA-N; [M+H]+; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.224; RNVIUPLZMWAIQD-UHFFFAOYNA-N; [M+H]+; Valyl-Gamma-glutamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.192; WBRUPBYQJCBBBL-UHFFFAOYSA-N; [M+H]+; 2-[4-(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MLTRLIITQPXHBJ-UHFFFAOYNA-N; [M+H]+; Leucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; HZYHBDVRCBDJJV-UHFFFAOYNA-N; [M+H]+; Isoleucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.839; HXWUJJADFMXNKA-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Leucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.839; MQLZLIYPFDIDMZ-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Isoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.794; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; Gly-Gly-Ile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; RNVIUPLZMWAIQD-UHFFFAOYNA-N; [M+H]+; Valyl-Gamma-glutamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.759; VWHGTYCRDRBSFI-ZETCQYMHSA-N; [M+H]+; Leu-Gly-Gly
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; XPJBQTCXPJNIFE-SSDOTTSWSA-N; [M+H]+; Gly-Gly-D-Leu
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.737; MRVYVEQPNDSWLH-BTBXXMRTNA-N; [M+H]+; Glutaminylvaline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.734; XXDVDTMEVBYRPK-UHFFFAOYNA-N; [M+H]+; Valyl-Glutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.722; QNBHZXFGRLNYRY-UHFFFAOYSA-N; [M+H]+; [4-[(2-amino-2-methylpropanoyl)amino]cyclohexyl] nitrate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.642; CGADBKNPQUQOIP-UHFFFAOYSA-N; [M+H]+; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.612; WBRUPBYQJCBBBL-UHFFFAOYSA-N; [M+H]+; 2-[4-(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.500; MLTRLIITQPXHBJ-UHFFFAOYSA-N; [M+H]+; 4-amino-2-[(2-amino-4-methylpentanoyl)amino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.414; HXWUJJADFMXNKA-UHFFFAOYSA-N; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.279; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; (2S,3S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.222; XXDVDTMEVBYRPK-XPUUQOCRSA-N; [M+H]+; (2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.646; HZYHBDVRCBDJJV-UHFFFAOYSA-N; [M+H]+; 4-amino-2-[(2-amino-3-methylpentanoyl)amino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.506; MQLZLIYPFDIDMZ-HAFWLYHUSA-N; [M+H]+; (2S,3S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; RNVIUPLZMWAIQD-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(2-amino-3-methylbutanoyl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; VWHGTYCRDRBSFI-UHFFFAOYSA-N; [M+H]+; 2-[[2-[(2-amino-4-methylpentanoyl)amino]acetyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; MRVYVEQPNDSWLH-XPUUQOCRSA-N; [M+H]+; (2S)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; XSXVXWAWKDJTCF-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-[(Z)-N'-hydroxycarbamimidoyl]morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; YDNSBSUBUKQVIV-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(hydrazinecarbonyl)morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -11.764; MQLZLIYPFDIDMZ; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -16.102; HXWUJJADFMXNKA; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.981; MLTRLIITQPXHBJ; [M+H]+; L-leucyl-L-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.044; MRVYVEQPNDSWLH; [M+H]+; 2-[(2,5-diamino-5-oxopentanoyl)amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.973; HZYHBDVRCBDJJV; [M+H]+; isoleucylasparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.061; XMPXVJIDADUOQB; [M+H]+; glycylglycylisoleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.915; XPJBQTCXPJNIFE; [M+H]+; glycylglycylleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.428; VWHGTYCRDRBSFI; [M+H]+; Leucylglycylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.357; XXDVDTMEVBYRPK; [M+H]+; Valylglutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.287; JRDYDYXZKFNNRQ; [M+H]+; ACMC-20mphf
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.162; CCBIBMKQNXHNIN; [M+H]+; glycylleucylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.484; KNBQDLQVANYHFJ; [M+H]+; l-Alanyl-l-alanyl-l-alanine methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.487; ASQFIHTXXMFENG; [M+H]+; Glycine, N-(N-L-valyl-L-alanyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.633; RNVIUPLZMWAIQD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.211; XDWLTSFLMBTXSP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -364.455; QNBHZXFGRLNYRY; [M+H]+; 2-Amino-2-methyl-N-(4-nitroxycyclohexyl)propionamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -426.279; AKEANMAEJCWJFI; [M+H]+; 2,4-Bis(Acetylamino)-2,4,6-Trideoxy-Beta-D-Glucopyranose
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -460.006; CGADBKNPQUQOIP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.437; MQLZLIYPFDIDMZ; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.940; MQLZLIYPFDIDMZ; [M+H]+; 2-(2-amino-3-carbamoylpropanamido)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.767; HXWUJJADFMXNKA; [M+H]+; 2-(2-amino-3-carbamoylpropanamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -133.643; XMPXVJIDADUOQB; [M+H]+; 2-[2-(2-Aminoacetamido)acetamido]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.623; XPJBQTCXPJNIFE; [M+H]+; Gly-Gly-D-leu
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.626; SMCGQGDVTPFXKB; [M+H]+; 2-[[2-(2-Aminopropanoylamino)acetyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -208.154; MLTRLIITQPXHBJ; [M+H]+; 2-(2-amino-4-methylpentanamido)-3-carbamoylpropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.686; HZYHBDVRCBDJJV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.402; JRDYDYXZKFNNRQ; [M+H]+; Glycyl-alanyl-valine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -230.264; MRVYVEQPNDSWLH; [M+H]+; 2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.534; HMHRTKOWRUPPNU; [M+H]+; 2-[[2-[(2-Aminoacetyl)amino]-3-methylpentanoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.837; MQLZLIYPFDIDMZ; [M+H]+; 2-(2-amino-3-carbamoylpropanamido)-3-methylpentanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Asparaginyl-Isoleucine, MQLZLIYPFDIDMZ-HAFWLYHUSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (6); This structural isomer was suggested from the biological context HMDB HMDB0028734;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H19N3O4
CH$EXACT_MASS: 245.137556
CH$SMILES: CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)N
CH$IUPAC: InChI=1S/C10H19N3O4/c1-3-5(2)8(10(16)17)13-9(15)6(11)4-7(12)14/h5-6,8H,3-4,11H2,1-2H3,(H2,12,14)(H,13,15)(H,16,17)/t5-,6-,8-/m0/s1
CH$NAME: Asparaginylisoleucine
CH$NAME: Asparaginyl-Isoleucine
CH$NAME: (2S,3S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-methylpentanoic acid
CH$LINK: INCHIKEY MQLZLIYPFDIDMZ-HAFWLYHUSA-N
CH$LINK: PUBCHEM CID:56991460
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.385
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 246.144498
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-029l-9800000000-d4a0a81b8121ee6bdadf
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.0385432 57.3369 41.038856 18.1293 23.93 0.7757 12 f{C3H5}/-0.81ppm,p-C7H15N3O4
  43.0171692 61.2492 43.017479 14.8313 39.73 0.1400 11 f{C2H3O1}/-15.62ppm,p-C8H17N3O3
  44.0494737 127.8721 44.049782 17.5257 47.03 0.7223 13 f{C2H6N1}/-0.04ppm,p-C8H14N2O4
  69.0699183 645.2378 69.070065 7.3114 149.16 0.8846 13 f{C5H9}/0.60ppm,p-C5H11N3O4
  70.0288924 187.8961 70.029042 9.1819 123.52 0.7318 13 f{C3H4N1O1}/2.17ppm,p-C7H16N2O3
  70.0654154 62.9997 70.065565 18.3400 42.37 -0.0794 13 f{C4H8N1}/4.14ppm,p-C6H12N2O4
  73.0397149 61.0429 73.039876 17.8670 22.38 0.8493 13 f{C2H5N2O1}/1.04ppm,p-C8H15N1O3
  73.0648878 75.0936 73.065049 17.6282 33.13 0.0941 13 f{C4H9O1}/1.32ppm,p-C6H11N3O3
  80.0124806 42.8848 80.012670 16.8224 19.43 0.4072 12 f{C4H2N1O1}/-7.62ppm,p-C6H18N2O3
  82.0291271 36.9105 82.029325 19.0786 10.99 0.8397 12 f{C4H4N1O1}/4.72ppm,p-C6H16N2O3
  84.0449034 89.0712 84.045110 18.9423 61.70 0.1621 10 f{C4H6N1O1}/6.11ppm,p-C6H14N2O3
  84.0804064 119.1601 84.080613 15.2711 58.38 -0.1375 13 f{C5H10N1}/-4.39ppm,p-C5H10N2O4
  85.0395982 314.8064 85.039809 4.7625 141.53 0.6813 13 f{C3H5N2O1}/-0.48ppm,p-C7H15N1O3
  86.0963975 557.0955 86.096613 6.9573 154.45 0.7088 13 f{C5H12N1}/-0.33ppm,p-C5H8N2O4
  87.0548270 548.0730 87.055047 6.7199 161.28 0.7802 13 f{C3H7N2O1}/-5.31ppm,p-C7H13N1O3
  96.0809884 125.9675 96.081251 12.2605 56.34 0.6575 13 f{C6H10N1}/2.21ppm,p-C4H10N2O4
  97.0653927 47.1609 97.065660 18.0806 19.80 0.6906 10 f{C6H9O1}/6.20ppm,p-C4H11N3O3
  98.0234103 355.4163 98.023682 6.0496 115.97 0.7637 13 f{C4H4N1O2}/-2.49ppm,p-C6H16N2O2
  110.0233585 782.3975 110.023694 6.3259 186.77 0.6923 13 f{C5H4N1O2}/-2.69ppm,p-C5H16N2O2
  113.1070866 485.8840 113.107439 6.1535 162.80 1.0000 13 f{C6H13N2}/-2.11ppm,p-C4H7N1O4
  115.0750900 75.1139 115.075454 9.2983 43.50 0.4833 13 f{C6H11O2}/-2.31ppm,p-C4H9N3O2
  124.0394295 285.0704 124.039847 8.8359 135.53 0.4869 13 f{C6H6N1O2}/1.00ppm,p-C4H14N2O2
  132.1012238 54.1723 132.101693 14.2315 26.18 0.8125 12 f{C6H14N1O2}/-5.16ppm,p-C4H6N2O2
  138.0908058 48.0890 138.091315 15.1857 24.89 0.4940 11 f{C8H12N1O1}/-3.87ppm,p-C2H8N2O3
  141.1022098 999.0000 141.102739 6.4351 60.81 0.7967 13 f{C7H13N2O1}/-0.21ppm,p-C3H7N1O3
  155.1179195 80.8680 155.118551 10.2309 33.26 0.5511 13 f{C8H15N2O1}/0.19ppm,p-C2H5N1O3
  166.0861037 445.3870 166.086867 7.1349 109.13 0.7308 13 f{C9H12N1O2}/-0.91ppm,p-C1H8N2O2
  183.1105472 50.2030 183.111566 23.2974 31.60 0.2534 10 f{C9H15N2O2}/-12.33ppm,p-C1H5N1O2
  187.1082787 80.3181 187.109362 16.4717 32.63 0.6267 13 f{C8H15N2O3}/2.99ppm,p-C2H5N1O1
  212.0925788 102.4600 212.094109 10.4671 41.08 0.8278 13 f{C10H14N1O4}/3.98ppm,p-H6N2
PK$NUM_PEAK: 30
PK$PEAK: m/z int. rel.int.
  41.038543 57.34 57
  43.017169 61.25 61
  44.049474 127.87 127
  69.069918 645.24 645
  70.028892 187.90 187
  70.065415 63.00 62
  73.039715 61.04 61
  73.064888 75.09 75
  80.012481 42.88 42
  82.029127 36.91 36
  84.044903 89.07 89
  84.080406 119.16 119
  85.039598 314.81 314
  86.096397 557.10 557
  87.054827 548.07 548
  96.080988 125.97 125
  97.065393 47.16 47
  98.023410 355.42 355
  110.023359 782.40 782
  113.107087 485.88 485
  115.075090 75.11 75
  124.039430 285.07 285
  132.101224 54.17 54
  138.090806 48.09 48
  141.102210 999.00 999
  155.117920 80.87 80
  166.086104 445.39 445
  183.110547 50.20 50
  187.108279 80.32 80
  212.092579 102.46 102
//
